NASDAQ: TALKTalkspace Inc Stock
$3.14+0.17 (+5.72%)
Updated Apr 19, 2024
TALK Price
$3.14
Fair Value Price
$3.91
Market Cap
$530.36M
52 Week Low
$0.74
52 Week High
$3.92
P/E
-26.17x
P/B
4.47x
P/S
2.79x
PEG
N/A
Dividend Yield
N/A
Revenue
$150.05M
Earnings
-$19.18M
Gross Margin
49.6%
Operating Margin
-15.47%
Profit Margin
-12.8%
Debt to Equity
0.2
Operating Cash Flow
-$16M
Beta
0.7
Next Earnings
Apr 30, 2024
Ex-Dividend
N/A
Next Dividend
N/A
TALK Overview
Talkspace Incorporated delivers virtual behavior healthcare through a web and mobile platform. Treatment options cover every need including psychiatry, and adolescent, individual, and couples therapy. Therapy is provided by a network of licensed therapists by way of chat/email messages, videos, voice messages, live videoconference sessions. The company was founded 2011 and is headquartered in New York, NY.
Zen Score
–
Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TALK scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
TALK ($3.14) is undervalued by 19.65% relative to our estimate of its Fair Value price of $3.91 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
TALK ($3.14) is not significantly undervalued (19.65%) relative to our estimate of its Fair Value price of $3.91 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
TALK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more TALK due diligence checks available for Premium users.
Be the first to know about important TALK news, forecast changes, insider trades & much more!
TALK News
Valuation
TALK fair value
Fair Value of TALK stock based on Discounted Cash Flow (DCF)
Price
$3.14
Fair Value
$3.91
Undervalued by
19.65%
TALK ($3.14) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
TALK ($3.14) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
TALK is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
TALK price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-26.17x
Industry
74.39x
Market
40.51x
TALK price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.47x
Industry
3.35x
TALK is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
TALK's financial health
Profit margin
Revenue
$42.4M
Net Income
-$1.3M
Profit Margin
-3.1%
TALK's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
TALK's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$142.2M
Liabilities
$23.6M
Debt to equity
0.2
TALK's short-term assets ($139.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TALK's short-term assets ($139.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TALK's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.5M
Investing
-$131.0k
Financing
$237.0k
TALK's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
TALK vs Health Information Service Stocks
Talkspace Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.